Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
allow to air dry completely
Self-pay patients: For patients without insurance coverage, or those receiving wellness injections that are not medically billable and common in functional medicine and IV therapy settings, practices should set a clear cash-pay rate
Andrea Corona Altimmunes GLP-1 drug shows positive results for alcohol use disorder On Tuesday, Altimmune announced topline data from their Phase 2 RECLAIM trial showing that pemvidutide, an investigational balanced glucagon/GLP-1 dual receptor agonist, significantly reduced the number of heavy drinking days compared to placebo in patients with moderate to severe alcohol use disorder
Related products Athletic Performance, Research Use Only $90.00 $150.00Price range: $90.00 through $150.00 Select options This product has multiple variants
GSH Standard Stock Diluent
US$ 25.50
US$ 24.62
US$ 27.43
US$ 22.64
US$ 29.71
